Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GENE ALTERATIONS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tanaka, N; Odajima, T; Mimura, M; Ogi, K; Dehari, H; Kimijima, Y; Kohama, G
      Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa

      ORAL ONCOLOGY
    2. Saida, T
      Recent advances in melanoma research

      JOURNAL OF DERMATOLOGICAL SCIENCE
    3. Omar, EA; Behlouli, H; Chevalier, S; Aprikian, AG
      Relationship of p21(WAF-1) protein expression with prognosis in advanced prostate cancer treated by androgen ablation

      PROSTATE
    4. Van Heerden, WFP; Swart, TJP; Robson, B; Smith, TL; Engelbrecht, S; Van Heerden, MB; Van Rensburg, EJ; Huebner, K
      FHIT RNA and protein expression in oral squamous cell carcinomas

      ANTICANCER RESEARCH
    5. Pulling, LC; Klinge, DM; Belinsky, SA
      p16(INK4a) and beta-catenin alterations in rat liver tumors induced by NNK

      CARCINOGENESIS
    6. Lukas, J; Gao, DQ; Keshmeshian, M; Wen, WH; Tsao-Wei, D; Rosenberg, S; Press, MF
      Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer

      CANCER RESEARCH
    7. Burton, JL; Oakley, N; Anderson, JB
      Recent advances in the histopathology and molecular biology of prostate cancer

      BJU INTERNATIONAL
    8. Sjostrom, J; Blomqvist, C; Heikkila, P; von Boguslawski, K; Raisanen-Sokolowski, A; Bengtsson, NO; Mjaaland, I; Malmstrom, P; Ostenstadt, B; Bergh, J; Wist, E; Valvere, V; Saksela, E
      Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer

      CLINICAL CANCER RESEARCH
    9. Beck, Z; Kiss, A; Toth, FD; Szabo, J; Bacsi, A; Balogh, E; Borbely, A; Telek, B; Kovacs, E; Olah, E; Rak, K
      Alterations of P53 and RB genes and the evolution of the accelerated phaseof chronic myeloid leukemia

      LEUKEMIA & LYMPHOMA
    10. Morikawa, H; Nakagawa, Y; Hashimoto, K; Niki, M; Egashira, Y; Hirata, I; Katsu, K; Akao, Y
      Frequent altered expression of fragile histidine triad protein in human colorectal adenomas

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    11. Kannan, K; Tharu, R; Gopinath, PM; Bharadwaj, TPR; Munirajan, AK; Tsuchida, N; Shanmugam, G
      Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome

      ONCOLOGY RESEARCH
    12. Moul, JV
      Angiogenesis, p53, bcl-2 and ki-67 in the progression of prostate cancer after radical prostatectomy

      EUROPEAN UROLOGY
    13. KUCZYK MA; SERTH J; BOKEMEYER C; SCHWEDE J; HERRMANN R; MACHTENS S; GRUNEWALD V; HOFNER K; JONAS U
      THE MXI1 TUMOR-SUPPRESSOR GENE IS NOT MUTATED IN PRIMARY PROSTATE-CANCER

      Oncology Reports
    14. HALLAK R; LOTTER O; SAFI F; JOUMA M
      EVALUATION OF AN IMMUNOLUMINOMETRIC BASED ASSAY AS A NOVEL METHOD FORTHE QUANTITATIVE-ANALYSIS OF P53 PROTEIN IN TUMOR-TISSUES

      Saudi medical journal
    15. Kiriu, H; Yokozaki, H; Yasui, W; Ito, K; Tahara, E
      Microsatellite instability associated with primary head and neck cancers and secondary esophageal cancers

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    16. Gunther, T; Schneider-Stock, R; Pross, M; Manger, T; Malfertheiner, P; Lippert, H; Roessner, A
      Alterations of the p16/MTS1 tumor suppressor gene in gastric cancer

      PATHOLOGY RESEARCH AND PRACTICE
    17. Elledge, RM; Allred, DC
      Prognostic and predictive value of p53 and p21 in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    18. Fowler, BA
      Roles of lead-binding proteins in mediating lead bioavailability

      ENVIRONMENTAL HEALTH PERSPECTIVES
    19. MILDELANGOSCH K; OCON E; BECKER G; LONING T
      P16 MTS1 INACTIVATION IN OVARIAN CARCINOMAS - HIGH-FREQUENCY OF REDUCED PROTEIN EXPRESSION ASSOCIATED WITH HYPER-METHYLATION OR MUTATION INENDOMETRIOID AND MUCINOUS TUMORS/

      International journal of cancer
    20. SOZZI G; PASTORINO U; MOIRAGHI L; TAGLIABUE E; PEZZELLA F; GHIRELLI C; TORNIELLI S; SARD L; HUEBNER K; PIEROTTI MA; CROCE CM; PILOTTI S
      LOSS OF FHIT FUNCTION IN LUNG-CANCER AND PREINVASIVE BRONCHIAL LESIONS

      Cancer research
    21. BAFFA R; VERONESE ML; SANTORO R; MANDES B; PALAZZO JP; RUGGE M; SANTORO E; CROCE CM; HUEBNER K
      LOSS OF FHIT EXPRESSION IN GASTRIC-CARCINOMA

      Cancer research
    22. KOVATICH A; FRIEDLAND DM; DRUCK T; HADACZEK P; HUEBNER K; COMIS RL; HAUCK W; MCCUE PA
      MOLECULAR ALTERATIONS TO HUMAN-CHROMOSOME 3P LOCI IN NEUROENDOCRINE LUNG-TUMORS

      Cancer
    23. CHENG RYS; YUEN PW; NICHOLLS JM; ZHENG Z; WEI W; SHAM JST; YANG XH; CAO L; HUANG DP; TSAO SW
      TELOMERASE ACTIVATION IN NASOPHARYNGEAL CARCINOMAS

      British Journal of Cancer
    24. LIZARDNACOL S; COUDERT B; RIEDINGER JM; FARGEOT P; GUERRIN J
      P53 GENE ALTERATIONS ARE ASSOCIATED WITH A DECREASED RESPONSIVENESS TO NEOADJUVANT CHEMOTHERAPY IN HUMAN BREAST-CANCER

      International journal of oncology
    25. LESEC G; RICHARDCOULET E; COLLET JF; DEMAUBLANC MA; MERLE S; SALMON RJ; REMVIKOS Y
      THE P53-POSITIVE PHENOTYPE OF BREAST CANCERS - CORRELATION WITH OTHERPARAMETERS AND CONSEQUENCES ON ITS BIOLOGICAL SIGNIFICANCE

      International journal of oncology
    26. SHIPMAN R; SCHRAML P; MOCH H; COLOMBI M; SAUTER G; MIHATSCH MJ; LUDWIG CU
      P53 PROTEIN ACCUMULATION AND P53 GENE ALTERATIONS (RFLP, VNTR AND P53GENE-MUTATIONS) IN NONINVASIVE VERSUS INVASIVE HUMAN TRANSITIONAL BLADDER-CANCER

      International journal of oncology
    27. RAILO M; LUNDIN J; HAGLUND C; VONSMITTEN K; VONBOGUSLAWSKY K; NORDLING S
      KI-67, P53, ER-RECEPTORS, PLOIDY AND S-PHASE AS PROGNOSTIC FACTORS INT1 NODE-NEGATIVE BREAST-CANCER

      Acta oncologica
    28. GIANNIKAKI E; KOUVIDOU C; TZARDI M; STEFANAKI K; KOUTSOUBI K; GREGORIOU M; ZOIS E; KAKOLYRIS S; MAVROUDI C; DELIDES G; GREGORIOU M; GEORGOULIAS V; KANAVAROS P
      P53 PROTEIN EXPRESSION IN BREAST CARCINOMAS - COMPARATIVE-STUDY WITH THE WILD-TYPE P53 INDUCED PROTEINS MDM2 AND P21 WAF1/

      Anticancer research
    29. MUTIRANGURA A; TANUNYUTTHAWONGESE C; PORNTHANAKASEM W; KEREKHANJANARONG V; SRIURANPONG V; YENRUDI S; SUPIYAPHUN P; VORAVUD N
      GENOMIC ALTERATIONS IN NASOPHARYNGEAL CARCINOMA - LOSS OF HETEROZYGOSITY AND EPSTEIN-BARR-VIRUS INFECTION

      British Journal of Cancer
    30. GORGOULIS VG; ZOUMPOURLIS V; RASSIDAKIS GZ; KARAMERIS A; RASSIDAKIS AN; SPANDIDOS DA; KITTAS C
      A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS AND P53 GENE-PRODUCT IN BRONCHOGENIC-CARCINOMA

      Journal of pathology
    31. ELLEDGE RM; FUQUA SAW; CLARK GM; PUJOL P; ALLRED DC
      THE ROLE AND PROGNOSTIC-SIGNIFICANCE OF P53 GENE ALTERATIONS IN BREAST-CANCER

      Breast cancer research and treatment


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 04:43:06